Myocarditis-myositis-myasthenia gravis overlap syndrome depending on immune checkpoint inhibitor

Immune checkpoint inhibitors are breakthrough monoclonal antibodies in cancer therapy developed against mechanisms that suppress the immune response. After the devastating effects of chemotherapy, these specific agents have given hope to cancer patients. However, every drug has side effects itself a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ünlütürk, Zeynep, Karagülmez, Ahmet Mağrur, Hayti, Barış, Erdoğan, Çağdaş
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific Scholar 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945139/
https://www.ncbi.nlm.nih.gov/pubmed/36891103
http://dx.doi.org/10.25259/JNRP_10_2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945139/
https://www.ncbi.nlm.nih.gov/pubmed/36891103
http://dx.doi.org/10.25259/JNRP_10_2022

Ejemplares similares